TNFSF4 antibody
-
- Target See all TNFSF4 Antibodies
- TNFSF4 (Tumor Necrosis Factor (Ligand) Superfamily, Member 4 (TNFSF4))
-
Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This TNFSF4 antibody is un-conjugated
-
Application
- Western Blotting (WB)
- Cross-Reactivity
- Human
- Purification
- Mouse monoclonal antibody supplied in crude ascites with 0.09% (W/V) sodium azide.
- Immunogen
- This TNFSF4 antibody is generated from mice immunized with a KLH conjugated synthetic peptide between 97-125 amino acids from human TNFSF4.
- Clone
- 3F3
- Isotype
- IgM
- Top Product
- Discover our top product TNFSF4 Primary Antibody
-
-
- Application Notes
- WB 1:300-5000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C for 12 months.
- Expiry Date
- 12 months
-
- Target
- TNFSF4 (Tumor Necrosis Factor (Ligand) Superfamily, Member 4 (TNFSF4))
- Alternative Name
- TNFSF4 (TNFSF4 Products)
- Synonyms
- TNFSF4 antibody, OX40L antibody, TNFRSF4 antibody, CD134L antibody, CD252 antibody, GP34 antibody, OX-40L antibody, OX4OL antibody, TXGP1 antibody, Ath-1 antibody, Ath1 antibody, Ox40l antibody, Txgp1l antibody, gp34 antibody, TNF superfamily member 4 antibody, tumor necrosis factor (ligand) superfamily, member 4 antibody, TNFSF4 antibody, Tnfsf4 antibody
- Background
-
Synonyms: GP34, CD252, OX4OL, TXGP1, CD134L, OX-40L, TNLG2B, Tumor necrosis factor ligand superfamily member 4, Glycoprotein Gp34, OX40 ligand, OX40L, TAX transcriptionally-activated glycoprotein 1, TNFSF4
Background: Cytokine that binds to TNFRSF4. Co-stimulates T-cell proliferation and cytokine production.
- Gene ID
- 7292
- UniProt
- P23510
- Pathways
- Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Activated T Cell Proliferation, Cancer Immune Checkpoints
-